Scienture Holdings vs 60 Degrees Pharmaceuticals
60 Degrees Pharmaceuticals is the larger business, with $1.0m of revenue in fiscal 2025 against $431,609 for Scienture Holdings (2.3 times as much). Scienture Holdings grew faster (215.9% against 65.5%). 60 Degrees Pharmaceuticals kept more of each dollar of sales as profit: a net margin of -732.5% against -9618.0%.
| Latest fiscal year | Scienture HoldingsSCNX, 2025 | 60 Degrees PharmaceuticalsSXTP, 2025 |
|---|---|---|
| Revenue | $431,609 | $1.0m |
| Revenue growth | 215.9% | 65.5% |
| Net income | −$41.5m | −$7.4m |
| Operating margin | -9867.9% | — |
| Net margin | -9618.0% | -732.5% |
| Return on equity | -55.6% | -196.4% |
| Free cash flow | −$13.4m | −$7.0m |
| Cash | $6.7m | $1.5m |
| Total debt | $2.0m | $152,775 |
| Debt to equity | 2.9% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | — |
| Market value | $134m | $2.6m |
| Price vs our value range | — | — |
| Moat score | 29 (Weak) | — |
| Insider trades, 12 months | 0 buys, 0 sales | 4 buys, 0 sales |